| News

Holmusk opens new office in Basel

18.01.2021

Holmusk has opened an office in Basel. The company from Singapore develops digital therapies on the basis of data analysis. Holmusk has placed a focus on the treatment of mental illnesses.

Nawal Roy, CEO of Holmusk (img: Holmusk)

Holmusk has recently moved into a new location at the Novartis Campus of the Switzerland Innovation Park Basel Area. The life sciences company develops data-driven digital therapies to treat a variety of disorders. Its focus is on mental and neurological illnesses, additionally Holmusk is active in the areas of cardiovascular and renal diseases, as well as diabetes.

The new office in Basel represents Holmusk’s seventh international office and second in Europe. According to Stefan Suter, Head of Holmusk Europe, staffing was a key consideration in the choice of Basel as a location: “In Basel we find multilingual, specialized talent from fresh graduates to seasoned professionals to be part of the data-driven revolution in healthcare”. In addition to current and future employees, the companies already located in Basel were also a significant pull factor for Holmusk. “Basel, with its large ecosystem of global leaders in life sciences offers multiple partnership opportunities and allows direct access to expand business into Germany or France”, explains Nawal Roy, CEO of Holmusk.

Holmusk is planning to build the world’s largest platform for what is known as real-world evidence (RWE), in which data from clinical practice is used to develop treatments. Holmusk has already been active in this area for five years, while the company also managed to successfully raise a total of 21.5 million US dollars in 2020 as part of a Series A financing round.

Switzerland Innovation Park Basel Area is operated by Basel Area Business & Innovation. The investment and innovation promotion agency also supported Holmusk during the process of establishing its business in the region.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BLKB supporting startups in Basel region
Basel Area Business & Innovation, Innovation

BLKB supporting startups in Basel region

Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...

Read More
BioVersys receives funding in the fight against tuberculosis
Basel Area Business & Innovation, Invest

BioVersys receives funding in the fight against tuberculosis

The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...

Read More
Biosynex takes up residence in Delémont
Basel Area Business & Innovation, Invest

Biosynex takes up residence in Delémont

The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has...

Read More
Novartis Campus opening further
Basel Area Business & Innovation, Switzerland Innovation Park

Novartis Campus opening further

Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...

Read More
docdok.health increases safety of coronavirus vaccinations
Basel Area Business & Innovation, Innovation

docdok.health increases safety of coronavirus vaccinations

The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...

Read More
Hemex attracts Swiss investors
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Hemex attracts Swiss investors

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...

Read More
1 2 3 40

Do you have a question? We'd like to hear from you.